Gemcitabine PhaRes 1 gm/vial (IV Infusion)
1 gm vial: ৳ 7,025.00
Medicine Details
Category | Details |
---|---|
Generic | Gemcitabine |
Company | Thymoorgan pharmazie gmbh germany |
Also available as |
Indications
- Non-Small Cell Lung Cancer treatment
- Pancreatic Cancer treatment
- Bladder Cancer treatment
- Breast Cancer treatment
- Ovarian Cancer treatment
Pharmacology
- Metabolized by nucleoside kinases
- Inhibition of DNA synthesis
- Inhibition of ribonucleotide reductase
- Competes with dCTP for incorporation into DNA
- Induces programmed cellular death process
Dosage & Administration
- Recommended doses for Non-Small Cell Lung Cancer
- Recommended doses for Pancreatic Cancer
- Recommended doses for Bladder Cancer
- Recommended doses for Breast Cancer
- Recommended doses for Ovarian Cancer
Interaction
- No confirmed interactions reported
- No specific drug interaction studies conducted
Contraindications
- Contraindicated in patients with known hypersensitivity to Gemcitabine
Side Effects
- Haematological Toxicity
- Hepatic Toxicity
- Gastrointestinal effects
- Genito-Urinary Toxicity
- Pulmonary Toxicity
- Allergic Toxicity
- Neurotoxicity
- Alopecia
Pregnancy & Lactation
- Pregnancy Category D
- Use during pregnancy
- Unknown excretion in human breast milk
Precautions & Warnings
- Caution for Schedule-dependent Toxicity
- Caution for Myelosuppression
- Caution for Pulmonary Toxicity and Respiratory Failure
- Caution for Hemolytic Uremic Syndrome
- Caution for Embryofetal Toxicity
- Caution for Radiation Therapy Toxicity
- Caution for Impairment of Fertility
Use in Special Populations
- Elderly Patients
- Renal and Hepatic Impairment
- Children
Overdose Effects
- No known antidote
- Principal toxicities include myelosuppression and paresthesias
Therapeutic Class
- Cytotoxic Chemotherapy
Storage Conditions
- Store at 20°C to 25°C away from light
- Do not refrigerate to avoid crystallization
- Keep out of reach of children
Related Brands
- Gemzar 200 mg/vial (IV Infusion) - eli-lilly-and-company
- Gemoxen 200 mg/vial (IV Infusion) - beacon-pharmaceuticals-plc
- Gitabin 200 mg/vial (IV Infusion) - bots-pvt-limited
- Gemcitabine PhaRes 200 mg/vial (IV Infusion) - thymoorgan-pharmazie-gmbh-germany
- Gemcetin 200 mg/vial (IV Infusion) - techno-drugs-ltd